Literature DB >> 22402802

Sources of drug coverage among Medicare beneficiaries with ESRD.

Benjamin L Howell1, Christopher A Powers, Eric D Weinhandl, Wendy L St Peter, Diane L Frankenfield.   

Abstract

Despite extensive use of prescription medications in ESRD, relatively little is known about the participation of Medicare ESRD beneficiaries in the Part D program. Here, we quantitated the sources of drug coverage among ESRD beneficiaries and explored the Part D plan preferences of ESRD beneficiaries with regard to deductibles, coverage gaps, and monthly premiums. We obtained data on beneficiary sources of creditable coverage, characteristics of Part D plans, demographics, and residence from the Centers for Medicare and Medicaid Chronic Condition Data Warehouse and identified beneficiaries with ESRD from the US Renal Data System. We found that a substantial proportion (17.0%) of ESRD beneficiaries lacked a known source of creditable drug coverage in 2007 and 64.3% were enrolled in Part D. Of those enrolled, 72% received the Medicare Part D low-income subsidy. ESRD beneficiaries who enrolled in standalone Part D plans without the assistance of the low-income subsidy tended to prefer more comprehensive coverage options. In conclusion, more outreach is needed to ensure that beneficiaries who lack coverage obtain the coverage they need and that ESRD beneficiaries join the best plans for managing their disease and accompanying comorbid conditions.

Entities:  

Mesh:

Year:  2012        PMID: 22402802      PMCID: PMC3338293          DOI: 10.1681/ASN.2011070740

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  19 in total

1.  Elders who delay medication because of cost: health insurance, demographic, health, and financial correlates.

Authors:  Dawn Klein; Carolyn Turvey; Robert Wallace
Journal:  Gerontologist       Date:  2004-12

2.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

Authors:  Jeppe N Rasmussen; Alice Chong; David A Alter
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

Review 3.  A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.

Authors:  John D Piette; Michele Heisler; Robert Horne; G Caleb Alexander
Journal:  Soc Sci Med       Date:  2005-08-10       Impact factor: 4.634

4.  Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.

Authors:  Diane L Frankenfield; Benjamin L Howell; Iris I Wei; Karyn K Anderson
Journal:  Am J Health Syst Pharm       Date:  2011-07-15       Impact factor: 2.637

5.  Why all prescribed medications are not taken: results from a survey of chronic dialysis patients.

Authors:  Jean L Holley; Cathy C DeVore
Journal:  Adv Perit Dial       Date:  2006

6.  Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.

Authors:  Uptal D Patel; Matthew M Davis
Journal:  J Am Soc Nephrol       Date:  2006-07-19       Impact factor: 10.121

Review 7.  A conceptual framework to study medication adherence in older adults.

Authors:  Michael D Murray; Daniel G Morrow; Michael Weiner; Daniel O Clark; Wanzhu Tu; Melissa M Deer; D Craig Brater; Morris Weinberger
Journal:  Am J Geriatr Pharmacother       Date:  2004-03

Review 8.  Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation.

Authors:  Mahmoud Loghman-Adham
Journal:  Am J Manag Care       Date:  2003-02       Impact factor: 2.229

9.  Effect of insurance on prescription drug use by ESRD beneficiaries.

Authors:  Y C Shih
Journal:  Health Care Financ Rev       Date:  1999

Review 10.  A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.

Authors:  Christina Karamanidou; Jane Clatworthy; John Weinman; Rob Horne
Journal:  BMC Nephrol       Date:  2008-01-31       Impact factor: 2.388

View more
  1 in total

1.  Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.

Authors:  Akeem A Yusuf; Benjamin L Howell; Christopher A Powers; Wendy L St Peter
Journal:  Am J Kidney Dis       Date:  2014-05-13       Impact factor: 8.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.